EcoR1 Capital, LLC bought AKTS
January 12, 2026 · Form 4 insider transaction
EcoR1 Capital, LLC bought 144,443 shares of Aktis Oncology, Inc. at $18.00 per share, a transaction worth $2.60M. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
144,443
Price
$18.00
Total value
$2.60M
InsiderEcoR1 Capital, LLC
Role—
CompanyAktis Oncology, Inc. (AKTS)
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateJanuary 12, 2026
Filing dateJanuary 12, 2026
Shares owned after347,305
OwnershipIndirect
10b5-1 planNo
AmendedNo
Footnotes
These securities are held by EcoR1 Capital Fund, L.P. ("Capital Fund"). EcoR1 may be deemed to indirectly beneficially own them as the investment adviser to and general partner of the fund. Mr. Nodelman may be deemed to indirectly beneficially own them as the control person of EcoR1.